Published in BMC Cancer on December 12, 2005
Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer. Breast Cancer Res (2007) 2.03
Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence. J Clin Oncol (2012) 1.85
Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study. Breast Cancer Res Treat (2010) 1.70
Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study. Breast Cancer Res (2008) 1.52
Prostaglandin E2 EP receptors as therapeutic targets in breast cancer. Cancer Metastasis Rev (2011) 1.21
Cyclooxygenase-2 and the inflammogenesis of breast cancer. World J Clin Oncol (2014) 1.15
Low-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trial. Br J Cancer (2008) 1.14
Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and risk of breast cancer among premenopausal women in the Nurses' Health Study II. Arch Intern Med (2009) 1.10
Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study. Cancer Causes Control (2010) 1.01
Exposure to cyclooxygenase-2 inhibitors and risk of cancer: nested case-control studies. Br J Cancer (2011) 0.94
Combination chemoprevention of HER2/neu-induced breast cancer using a cyclooxygenase-2 inhibitor and a retinoid X receptor-selective retinoid. Cancer Prev Res (Phila) (2008) 0.87
Regular aspirin use and breast cancer risk in US Black women. Cancer Causes Control (2011) 0.85
Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control study. Breast Cancer Res (2010) 0.85
The case for developing publicly-accessible datasets for health services research in the Middle East and North Africa (MENA) region. BMC Health Serv Res (2009) 0.85
Modulation of breast cancer risk by nonsteroidal anti-inflammatory drugs. J Natl Cancer Inst (2008) 0.84
Nonsteroidal anti-inflammatory drugs and change in mammographic density: a cohort study using pharmacy records on over 29,000 postmenopausal women. Cancer Epidemiol Biomarkers Prev (2008) 0.82
Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study. J Natl Cancer Inst (2015) 0.81
Personalizing Aspirin Use for Targeted Breast Cancer Chemoprevention in Postmenopausal Women. Mayo Clin Proc (2015) 0.79
Preventative therapies for healthy women at high risk of breast cancer. Cancer Manag Res (2014) 0.78
Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) study. BMC Cancer (2016) 0.75
The Role of NSAIDs in Breast Cancer Prevention and Relapse: Current Evidence and Future Perspectives. Breast Care (Basel) (2016) 0.75
Use of acetaminophen in relation to the occurrence of cancer: a review of epidemiologic studies. Cancer Causes Control (2016) 0.75
Impact of acetylsalicylic Acid on the clinicopathological characteristics and prognosis of patients with invasive breast cancer. Breast Care (Basel) (2014) 0.75
Concern Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med (2000) 29.03
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med (2005) 15.46
Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med (2005) 12.46
A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med (2003) 9.18
Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA (2005) 9.03
A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med (2003) 6.99
The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med (2002) 5.17
Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol (2000) 4.83
Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk. JAMA (2004) 4.31
The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Québec. J Clin Epidemiol (1995) 3.99
Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst (1998) 2.67
Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative. Cancer Res (2003) 2.49
Association between naproxen use and protection against acute myocardial infarction. Arch Intern Med (2002) 2.45
Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res (1996) 2.27
Platelet-active drugs : the relationships among dose, effectiveness, and side effects. Chest (2001) 2.25
Breast cancer and NSAID use: a meta-analysis. Br J Cancer (2001) 2.21
Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor. Cancer Res (2000) 2.12
Nonsteroidal anti-inflammatory drug use and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2001) 1.83
The cyclooxygenase-2-selective inhibitors rofecoxib and celecoxib prevent colorectal neoplasia occurrence and recurrence. Gastroenterology (2003) 1.62
Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer. Cancer Res (2002) 1.59
Understanding the relationship between body weight and osteoarthritis. Baillieres Clin Rheumatol (1997) 1.39
Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer. Cancer Epidemiol Biomarkers Prev (2002) 1.35
Use of nonsteroidal antiinflammatory drugs and risk of breast cancer: the Case-Control Surveillance Study revisited. Am J Epidemiol (2005) 1.25
Risk of breast cancer among users of aspirin and other anti-inflammatory drugs. Br J Cancer (2004) 1.20
Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort. Cancer Epidemiol Biomarkers Prev (2005) 1.20
Effects of chronic indomethacin therapy on the development and progression of spontaneous mammary tumors in C3H/HEJ mice. Int J Cancer (1997) 1.06
Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor. Clin Cancer Res (2000) 1.05
Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breast. Cancer Causes Control (2003) 1.04
Effect of the prostaglandin synthetase inhibitor indomethacin on 7,12-dimethylbenz(a)anthracene-induced mammary tumorigenesis in rats fed different levels of fat. Cancer Res (1983) 1.02
Gastrointestinal health care resource use and costs associated with nonsteroidal antiinflammatory drugs versus acetaminophen: retrospective cohort study of an elderly population. Arthritis Rheum (2000) 1.01
A comparison of the efficacy and safety of nonsteroidal antiinflammatory agents versus acetaminophen in the treatment of osteoarthritis: a meta-analysis. Arthritis Rheum (2004) 1.00
Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis. Anticancer Res (2002) 0.99
Use of NSAIDs, COX-2 inhibitors, and acetaminophen and associated coprescriptions of gastroprotective agents in an elderly population. Arthritis Rheum (2002) 0.98
Association of regular aspirin use and breast cancer risk. Oncology (2005) 0.97
A comprehensive view of sex-specific issues related to cardiovascular disease. CMAJ (2007) 2.35
Utility of the Patient Health Questionnaire-9 to assess suicide risk in patients with systemic sclerosis. Arthritis Care Res (Hoboken) (2013) 2.14
Clinical and serologic correlates of anti-PM/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients. Arthritis Rheumatol (2014) 1.99
Antirheumatic drug use and the risk of acute myocardial infarction. Arthritis Rheum (2006) 1.99
The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol (2013) 1.85
Association between nonsteroidal anti-inflammatory drugs and prostate cancer occurrence. Cancer J (2006) 1.78
High prevalence of occult left heart disease in scleroderma-pulmonary hypertension. Eur Respir J (2012) 1.62
Sex differences in acute coronary syndrome symptom presentation in young patients. JAMA Intern Med (2013) 1.45
Systemic sclerosis in Canada's North American Native population: assessment of clinical and serological manifestations. J Rheumatol (2013) 1.39
Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction. CMAJ (2011) 1.18
The clinimetric properties of the World Health Organization Disability Assessment Schedule II in early inflammatory arthritis. Arthritis Rheum (2008) 1.18
The development of systemic sclerosis classification criteria. Clin Rheumatol (2007) 1.17
14-year diabetes incidence: the role of socio-economic status. Health Rep (2010) 1.17
Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey. Rheumatology (Oxford) (2010) 1.15
Comparison of the PHQ-9 and CES-D depression scales in systemic sclerosis: internal consistency reliability, convergent validity and clinical correlates. Rheumatology (Oxford) (2010) 1.15
Depression in patients with systemic sclerosis: a systematic review of the evidence. Arthritis Rheum (2007) 1.15
Using diffusion of innovations theory to guide diabetes management program development: an illustrative example. J Public Health (Oxf) (2007) 1.13
Office capillaroscopy in systemic sclerosis. Clin Rheumatol (2006) 1.11
Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA. J Rheumatol (2007) 1.08
Postdischarge thromboprophylaxis and mortality risk after hip-or knee-replacement surgery. CMAJ (2008) 1.07
Reliability and validity of the center for epidemiologic studies depression scale in patients with systemic sclerosis. Arthritis Rheum (2008) 1.07
Systematic review and meta-analysis of validation studies on a diabetes case definition from health administrative records. PLoS One (2013) 1.05
The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses. Arthritis Res Ther (2011) 1.04
Prevalence and clinical correlates of symptoms of depression in patients with systemic sclerosis. Arthritis Rheum (2008) 1.03
Psychological health and well-being in systemic sclerosis: State of the science and consensus research agenda. Arthritis Care Res (Hoboken) (2010) 1.03
Corticosteroids and the risk of scleroderma renal crisis: a systematic review. Rheumatol Int (2010) 1.03
Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-risk prostate cancer: preliminary toxicity analysis of RTOG 99-02. Int J Radiat Oncol Biol Phys (2008) 1.03
2013 American College of Rheumatology/European League against rheumatism classification criteria for systemic sclerosis outperform the 1980 criteria: data from the Canadian Scleroderma Research Group. Arthritis Care Res (Hoboken) (2015) 1.02
The 1000 Canadian faces of lupus: determinants of disease outcome in a large multiethnic cohort. J Rheumatol (2009) 1.00
Sex differences in step count-blood pressure association: a preliminary study in type 2 diabetes. PLoS One (2010) 0.99
Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancer. Am J Clin Oncol (2009) 0.97
Determinants of sleep quality in women with systemic lupus erythematosus. Arthritis Rheum (2005) 0.97
Combined oral contraceptive use and the risk of systemic lupus erythematosus. Arthritis Rheum (2009) 0.96
An algorithm to differentiate diabetic respondents in the Canadian Community Health Survey. Health Rep (2008) 0.96
Prevalence, severity, and clinical correlates of pain in patients with systemic sclerosis. Arthritis Care Res (Hoboken) (2010) 0.96
Bayesian modelling of imperfect ascertainment methods in cancer studies. Stat Med (2005) 0.95
The cost of systemic sclerosis. Arthritis Rheum (2009) 0.94
Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis. Arthritis Care Res (Hoboken) (2012) 0.94
New directions for patient-centred care in scleroderma: the Scleroderma Patient-centred Intervention Network (SPIN). Clin Exp Rheumatol (2012) 0.94
Sociodemographic, disease, and symptom correlates of fatigue in systemic sclerosis: evidence from a sample of 659 Canadian Scleroderma Research Group Registry patients. Arthritis Rheum (2009) 0.94
Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort. Semin Arthritis Rheum (2012) 0.93
Prevalence of factors influencing cancer risk in women with lupus: social habits, reproductive issues, and obesity. J Rheumatol (2002) 0.92
Estimating the population prevalence of diagnosed and undiagnosed diabetes. Diabetes Care (2013) 0.92
Outcomes in a diabetic population of South Asians and whites following hospitalization for acute myocardial infarction: a retrospective cohort study. Cardiovasc Diabetol (2010) 0.91
Screening and therapy for malnutrition and related gastro-intestinal disorders in systemic sclerosis: recommendations of a North American expert panel. Clin Exp Rheumatol (2010) 0.91
TNF-alpha antagonists and the prevention of hospitalisation for chronic obstructive pulmonary disease. Pulm Pharmacol Ther (2007) 0.90
Dimensions of fatigue in systemic lupus erythematosus: relationship to disease status and behavioral and psychosocial factors. J Rheumatol (2006) 0.90
Symptoms of depression predict the trajectory of pain among patients with early inflammatory arthritis: a path analysis approach to assessing change. J Rheumatol (2009) 0.88
Development and validation of the brief-satisfaction with appearance scale for systemic sclerosis. Arthritis Care Res (Hoboken) (2010) 0.88
(Not) talking about sex: a systematic comparison of sexual impairment in women with systemic sclerosis and other chronic disease samples. Rheumatology (Oxford) (2009) 0.87
Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis. Arthritis Rheum (2006) 0.87
Chronic smoke exposure induces rheumatoid factor and anti-heat shock protein 70 autoantibodies in susceptible mice and humans with lung disease. Eur J Immunol (2012) 0.87
Medication use in systemic lupus erythematosus. J Rheumatol (2010) 0.86
Major depression diagnoses among patients with systemic sclerosis: baseline and one-month followup. Arthritis Care Res (Hoboken) (2015) 0.85
Vascular access-related bloodstream infections in First Nations, community and teaching Canadian dialysis units, and other centre-level predictors. Nephron Clin Pract (2009) 0.85
Risks of suicide and poisoning among elderly patients prescribed selective serotonin reuptake inhibitors: a retrospective cohort study. J Clin Psychiatry (2008) 0.85
Consensus opinion of a North American Working Group regarding the classification of digital ulcers in systemic sclerosis. Clin Rheumatol (2013) 0.85
Malnutrition is common in systemic sclerosis: results from the Canadian scleroderma research group database. J Rheumatol (2009) 0.84
Effect of chronic intake of NSAIDs and cyclooxygenase 2-selective inhibitors on esophageal cancer incidence. Clin Gastroenterol Hepatol (2004) 0.84
Association of gastroesophageal factors and worsening of forced vital capacity in systemic sclerosis. J Rheumatol (2013) 0.84
High rates of depressive symptoms among patients with systemic sclerosis are not explained by differential reporting of somatic symptoms. Arthritis Rheum (2008) 0.84
Measuring fatigue in SSc: a comparison of the Short Form-36 Vitality subscale and Functional Assessment of Chronic Illness Therapy-Fatigue scale. Rheumatology (Oxford) (2012) 0.83
Differences in food intake among obese and nonobese women and men with type 2 diabetes. J Am Coll Nutr (2011) 0.83
Neighborhood walkability: field validation of geographic information system measures. Am J Prev Med (2013) 0.83
Prevalence and clinical correlates of pruritus in patients with systemic sclerosis. Arthritis Rheum (2009) 0.83
Systemic autoimmune rheumatic disease prevalence in Canada: updated analyses across 7 provinces. J Rheumatol (2014) 0.83
Disability in systemic sclerosis -- a longitudinal observational study. J Rheumatol (2010) 0.83
Sociodemographic and disease correlates of body image distress among patients with systemic sclerosis. PLoS One (2012) 0.83
Validation of the UCLA Scleroderma Clinica Trial Gastrointestinal Tract Instrument version 2.0 for systemic sclerosis. J Rheumatol (2011) 0.82
Relationship between disease characteristics and orofacial manifestations in systemic sclerosis: Canadian Systemic Sclerosis Oral Health Study III. Arthritis Care Res (Hoboken) (2015) 0.82
Prevalence of current, 12-month and lifetime major depressive disorder among patients with systemic sclerosis. Rheumatology (Oxford) (2012) 0.82
Response to chemotherapy in metastatic colorectal cancer after exposure to oxaliplatin in the adjuvant setting. Anticancer Res (2013) 0.82
Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA. Clin Chim Acta (2011) 0.81
Short-term mortality associated with failure to receive home care after hemiarthroplasty. CMAJ (2010) 0.81
Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis. BMC Med (2009) 0.81
Influence of somatic symptoms on Patient Health Questionnaire-9 depression scores among patients with systemic sclerosis compared to a healthy general population sample. Arthritis Care Res (Hoboken) (2012) 0.80
Breast cancer stage at time of detection in women with systemic lupus erythematosus. Lupus (2004) 0.80
Rates and correlates of sexual activity and impairment among women with systemic sclerosis. Arthritis Care Res (Hoboken) (2012) 0.80
Demographic and clinical factors associated with physician service use in systemic sclerosis. J Rheumatol (2009) 0.79
Association of smoking with cutaneous manifestations in systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2013) 0.79
Gestational diabetes history may signal deprivation in women with type 2 diabetes. J Womens Health (Larchmt) (2011) 0.79
Association of pruritus with quality of life and disability in systemic sclerosis. Arthritis Care Res (Hoboken) (2010) 0.79
Do traditional Gail model risk factors account for increased breast cancer in women with lupus? J Rheumatol (2003) 0.79
Is serum albumin a marker of malnutrition in chronic disease? The scleroderma paradigm. J Am Coll Nutr (2010) 0.79
Sleep disturbances in systemic sclerosis: evidence for the role of gastrointestinal symptoms, pain and pruritus. Rheumatology (Oxford) (2013) 0.78
Sexual activity and impairment in women with systemic sclerosis compared to women from a general population sample. PLoS One (2012) 0.78
Adjuvant treatment for endometrial cancer: literature review and recommendations by the Comité de l'évolution des pratiques en oncologie (CEPO). Gynecol Oncol (2013) 0.78
Pancytopenia and atrial fibrillation associated with chronic hepatitis C infection and presumed hepatocellular carcinoma: a case report. J Med Case Rep (2008) 0.78
Newer disease-modifying antirheumatic drugs and the risk of serious hepatic adverse events in patients with rheumatoid arthritis. Am J Med (2004) 0.78
Effect of menopause on the modified Rodnan skin score in systemic sclerosis. Arthritis Res Ther (2014) 0.78
Cross-language measurement equivalence of the Center for Epidemiologic Studies Depression (CES-D) scale in systemic sclerosis: a comparison of Canadian and Dutch patients. PLoS One (2013) 0.78
Is there an association between Ro52/TRIM21 antibodies and rheumatoid factor in systemic sclerosis? Rheumatol Int (2013) 0.77
Healthcare costs of inflammatory myopathies. J Rheumatol (2011) 0.77
Physical and occupational therapy referral and use among systemic sclerosis patients with impaired hand function: results from a Canadian national survey. Clin Exp Rheumatol (2012) 0.77
Are scores on English and French versions of the PHQ-9 comparable? An assessment of differential item functioning. PLoS One (2012) 0.77
Assessment of reproductive history in systemic sclerosis. Arthritis Rheum (2008) 0.77
Contemporary outcome and management of patients who had an aborted cystectomy due to unresectable bladder cancer. Urol Oncol (2009) 0.77